On April 28, 2025, the Board of Directors (the “Board”) of Tharimmune, Inc. (the “Company”) increased the size of the Board to nine members and appointed each of Clay Kahler and Gary Stetz as members of the Board.
On April 28, 2025, the Board of Directors (the “Board”) of Tharimmune, Inc. (the “Company”) increased the size of the Board to nine members and appointed each of Clay Kahler and Gary Stetz as members of the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Gary Stetz was appointed as member of the Board at Canton Strategic Holdings, Inc..
Action
appointed
Role
member of the Board
Exact text from the filing
On April 28, 2025, the Board of Directors (the “Board”) of Tharimmune, Inc. (the “Company”) increased the size of the Board to nine members and appointed each of Clay Kahler and Gary Stetz as members of the Board.
Clay Kahler was appointed as member of the Board at Canton Strategic Holdings, Inc..
Action
appointed
Role
member of the Board
Exact text from the filing
On April 28, 2025, the Board of Directors (the “Board”) of Tharimmune, Inc. (the “Company”) increased the size of the Board to nine members and appointed each of Clay Kahler and Gary Stetz as members of the Board.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.